Brief: Aker Biomarine Q2 Adjusted EBITDA USD 21 Million, Up 11% y-o-y
July 14 (Reuters) - Aker Biomarine ASA AKBM.OL :
* REVENUES OF USD 73 MILLION AND ADJUSTED EBITDA OF USD 21
MILLION
FOR Q2 2022.
* Q2 REVENUES OF USD 73 MILLION, ON PAR WITH SAME QUARTER
LAST
YEAR
* Q2 ADJUSTED EBITDA OF USD 21 MILLION, UP 11% FROM SAME
QUARTER
LAST YEAR
* ECONREITERATES ITS TARGETS FOR 2022
Source text for Eikon: ID:nObiLgrBja
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million